Comparison of Different Assays To Assess Human Papillomavirus (HPV) Type 16- and 18-Specific Antibodies after HPV Infection and Vaccination-Reference-Cited by-同舟云学术

Comparison of Different Assays To Assess Human Papillomavirus (HPV) Type 16- and 18-Specific Antibodies after HPV Infection and Vaccination

Published:2013-08 Issue:8 Volume:20 Page:1329-1332
ISSN:1556-6811
Container-title:Clinical and Vaccine Immunology
language:en
Short-container-title:Clin Vaccine Immunol

Author:

Scherpenisse Mirte¹²,Schepp Rutger M.¹,Mollers Madelief³²,Mooij Sofie H.⁴,Meijer Chris J. L. M.²,Berbers Guy A. M.¹,van der Klis Fiona R. M.¹

Affiliation:

1. Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, the Netherlands

2. Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands

3. Department of Epidemiology and Surveillance, National Institute of Public Health and the Environment, Bilthoven, the Netherlands

4. Public Health Service of Amsterdam (GGD), Amsterdam, the Netherlands

Abstract

ABSTRACT We compared the measurement of human papillomavirus (HPV)-specific serum antibody levels with the virus-like-particle multiplex immunoassay (VLP-MIA), competitive Luminex immunoassay (cLIA), and glutathione S -transferase (GST) L1-based MIA. Using a large panel of serum samples, these assays showed mutually good correlations for both naturally induced and vaccine-derived HPV-specific antibody levels. However, an adaptation of the GST L1-based MIA resulted in an improved correlation with both cLIA and VLP-MIA.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://journals.asm.org/doi/pdf/10.1128/CVI.00153-13

Reference18 articles.

1. Stability over time of serum antibody levels to human papillomavirus type 16;af Geijersstam V;J. Infect. Dis.,1998

2. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18;Pastrana DV;Virology,2004

3. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J;Kirnbauer R;Natl. Cancer Inst.,1994

4. Optimization and validation of a multiplexed Luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin;Dias D;Diagn. Lab. Immunol.,2005

5. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins;Waterboer T;Clin. Chem.,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity;Human Vaccines & Immunotherapeutics;2024-04-03

2. Multiplex immunoassay to measure antibody response to nine HPV vaccine types;Journal of Immunological Methods;2021-11

3. Immune surveillance for vaccine-preventable diseases;Expert Review of Vaccines;2020-03-29

4. Persisting Antibody Response 9 Years After Bivalent Human Papillomavirus (HPV) Vaccination in a Cohort of Dutch Women: Immune Response and the Relation to Genital HPV Infections;The Journal of Infectious Diseases;2020-01-09

5. Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology;Cellular and Molecular Life Sciences;2018-10-16